132 related articles for article (PubMed ID: 36063987)
21. Association of Immunosuppression With Outcomes of Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck.
Tam S; Yao CMKL; Amit M; Gajera M; Luo X; Treistman R; Khanna A; Aashiq M; Nagarajan P; Bell D; El-Naggar A; Migden M; Wong M; Glisson B; Ferrarotto R; Esmaeli B; Rosenthal D; Li G; Weber RS; Myers JN; Gross ND
JAMA Otolaryngol Head Neck Surg; 2020 Feb; 146(2):128-135. PubMed ID: 31804658
[TBL] [Abstract][Full Text] [Related]
22. Brigham and Women's Hospital tumor classification system for basal cell carcinoma identifies patients with risk of metastasis and death.
Morgan FC; Ruiz ES; Karia PS; Besaw RJ; Neel VA; Schmults CD
J Am Acad Dermatol; 2021 Sep; 85(3):582-587. PubMed ID: 33497751
[TBL] [Abstract][Full Text] [Related]
23. Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women's Hospital Tumor Classification System for Cutaneous Squamous Cell Carcinoma.
Ruiz ES; Karia PS; Besaw R; Schmults CD
JAMA Dermatol; 2019 Jul; 155(7):819-825. PubMed ID: 30969315
[TBL] [Abstract][Full Text] [Related]
24. Metastatic Cutaneous Squamous Cell Carcinoma: The Importance of T2 Stratification and Hematologic Malignancy in Prognostication.
Stevenson ML; Kim R; Meehan SA; Pavlick AC; Carucci JA
Dermatol Surg; 2016 Aug; 42(8):932-5. PubMed ID: 27467226
[TBL] [Abstract][Full Text] [Related]
25. Comparing the eighth and the seventh editions of the American Joint Committee on Cancer staging system and the Brigham and Women's Hospital alternative staging system for cutaneous squamous cell carcinoma: Implications for clinical practice.
Cañueto J; Burguillo J; Moyano-Bueno D; Viñolas-Cuadros A; Conde-Ferreirós A; Corchete-Sánchez LA; Pérez-Losada J; Román-Curto C
J Am Acad Dermatol; 2019 Jan; 80(1):106-113.e2. PubMed ID: 30003984
[TBL] [Abstract][Full Text] [Related]
26. Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: A 5-year, multicenter, prospective cohort study.
Tschetter AJ; Campoli MR; Zitelli JA; Brodland DG
J Am Acad Dermatol; 2020 Jan; 82(1):139-148. PubMed ID: 31279037
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Tumor Classifications for Cutaneous Squamous Cell Carcinoma of the Head and Neck in the 7th vs 8th Edition of the AJCC Cancer Staging Manual.
Karia PS; Morgan FC; Califano JA; Schmults CD
JAMA Dermatol; 2018 Feb; 154(2):175-181. PubMed ID: 29261835
[TBL] [Abstract][Full Text] [Related]
28. Performance of Staging Systems for Non-Head and Neck Cutaneous Squamous Cell Carcinoma.
Guerra R; Shahwan KT; Nikahd M; Hyer M; Carr DR
Dermatol Surg; 2024 Feb; 50(2):121-124. PubMed ID: 37962141
[TBL] [Abstract][Full Text] [Related]
29. Performance of Salamanca refinement of the T3-AJCC8 versus the Brigham and Women's Hospital and Tübingen alternative staging systems for high-risk cutaneous squamous cell carcinoma.
Puebla-Tornero L; Corchete-Sánchez LA; Conde-Ferreirós A; García-Sancha N; Corchado-Cobos R; Román-Curto C; Cañueto J
J Am Acad Dermatol; 2021 Apr; 84(4):938-945. PubMed ID: 33333151
[TBL] [Abstract][Full Text] [Related]
30. Validating 4 Staging Systems for Cutaneous Squamous Cell Carcinoma Using Population-Based Data: A Nested Case-Control Study.
Roscher I; Falk RS; Vos L; Clausen OPF; Helsing P; Gjersvik P; Robsahm TE
JAMA Dermatol; 2018 Apr; 154(4):428-434. PubMed ID: 29516080
[TBL] [Abstract][Full Text] [Related]
31. Rate of regional nodal metastases of cutaneous squamous cell carcinoma in the immunosuppressed patient.
McLaughlin EJ; Miller L; Shin TM; Sobanko JF; Cannady SB; Miller CJ; Newman JG
Am J Otolaryngol; 2017; 38(3):325-328. PubMed ID: 28202188
[TBL] [Abstract][Full Text] [Related]
32. Cutaneous squamous cell carcinoma tumor accrual rates in immunosuppressed patients with autoimmune and inflammatory conditions: A retrospective cohort study.
Granger EE; Groover M; Harwood C; Proby CM; Karn E; Murad F; Schmults CD; Ruiz ES
J Am Acad Dermatol; 2024 Apr; 90(4):731-738. PubMed ID: 38043592
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for lymph node metastasis in cutaneous squamous cell carcinoma: a long-term retrospective study of Japanese patients.
Saito Y; Fujikawa H; Takatsuka S; Abe R; Takenouchi T
Int J Clin Oncol; 2021 Mar; 26(3):606-612. PubMed ID: 33175299
[TBL] [Abstract][Full Text] [Related]
34. Parotid metastatic disease from cutaneous squamous cell carcinoma: prognostic role of facial nerve sacrifice, lateral temporal bone resection, immune status and P-stage.
Shao A; Wong DK; McIvor NP; Mylnarek AM; Chaplin JM; Izzard ME; Patel RS; Morton RP
Head Neck; 2014 Apr; 36(4):545-50. PubMed ID: 23780509
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous squamous cell carcinomas with markers of increased metastatic risk are associated with elevated numbers of neutrophils and/or granulocytic myeloid derived suppressor cells.
Seddon A; Hock B; Miller A; Frei L; Pearson J; McKenzie J; Simcock J; Currie M
J Dermatol Sci; 2016 Aug; 83(2):124-30. PubMed ID: 27160951
[TBL] [Abstract][Full Text] [Related]
36. Validation Study of the AJCC Cancer Staging Manual, Eighth Edition, Staging System for Eyelid and Periocular Squamous Cell Carcinoma.
Xu S; Sagiv O; Rubin ML; Sa HS; Tetzlaff MT; Nagarajan P; Ning J; Esmaeli B
JAMA Ophthalmol; 2019 May; 137(5):537-542. PubMed ID: 30869769
[TBL] [Abstract][Full Text] [Related]
37. The 7th edition AJCC staging system for cutaneous squamous cell carcinoma accurately predicts risk of recurrence for heart and lung transplant recipients.
Metchnikoff C; Mully T; Singer JP; Golden JA; Arron ST
J Am Acad Dermatol; 2012 Nov; 67(5):829-35. PubMed ID: 22285618
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Outcomes of Cutaneous Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Retrospective Comparative Cohort Study.
Salido-Vallejo R; Escribano-Castillo L; Antoñanzas J; Roldán-Córdoba C; Velez A; Aguado-Gil L
J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137687
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Value of Tumor Staging: Predicting Nodal Metastases in Cutaneous Squamous Cell Carcinoma.
Upton M; Kita A; Scapa J; St John M
Laryngoscope; 2021 Jan; 131(1):E170-E175. PubMed ID: 32212346
[TBL] [Abstract][Full Text] [Related]
40. Clinical outcomes of high-risk cutaneous squamous cell carcinomas treated with Mohs surgery alone: An analysis of local recurrence, regional nodal metastases, progression-free survival, and disease-specific death.
Soleymani T; Brodland DG; Arzeno J; Sharon DJ; Zitelli JA
J Am Acad Dermatol; 2023 Jan; 88(1):109-117. PubMed ID: 35760236
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
